Skip to content

TECO®Fast Aspergillus Galactomannan Antigen Rapid 

Key Features


Fluorescence Lateral Flow Assay for the fast single test determination of Aspergillus- Galactomannan antigen in human serum and bronchoalveolar lavage (BAL) for the detection of invasive Aspergillosis.

Product Description



The mortality rate of Invasive Aspergillosis ranges from 60 to 100% without timely treatment, thus prompt determination of galactomannan antigen may be essential.


  • Lateral flow assay in combination with fluorescence detection.
  • Validated for serum and BAL samples.
  • Simple sample preparation and 20 minutes incubation on test cassette.
  • Automatic measurement on FIC-Q100N reader with calculation of index values.
  • Flexible workflow with and without incubation on board.
  • Transmission of results to internal printer, Excel file and LIS system.
  • > 93% coincidence with established ELISA tests.

Request Quotation


Product
SKU
Pack Size
Qty
TECO®Fast Aspergillus Galactomannan Antigen Rapid
SKU
TE1069
Pack Size
96 tests

Request Documentation


TECO®Fast Aspergillus Galactomannan Antigen Rapid
TE1069

Latest News


Hepatitis D Virus: Diagnostic Complexity and Public Health Challanges in 2025

During this webinar, Frédéric LE GAL, PhD (HDR), specialist in Hepatitis Delta Virus at the National Reference Center for HDV in France, will present all these diagnostic difficulties in relation to the characteristics of the virus with a view to improving tests for wide dissemination of screening and shedding light on the global epidemiology of this virus.

Meet us at BLTG meeting!

The British Association for the Study of Liver (BASL) Annual Meeting 2025 is being held at the ICC in the heart of Belfast city during October 7th-9th. Eurobio Scientific UK will be exhibiting at the British Liver Transplant Group (BLTG) Meeting on October 7th, bringing to you the innovative PEVIVA range from VLVbio. We invite you to come along and meet us to learn more.

New Solution to Perform Specialities in Every Laboratory

Automatic multi-parameter random access system for immunoassays with ready-to-use monotest devices.

Emissions Report for January - June 2025

Contact Us